OrbiMed Advisors Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
OrbiMed Advisors Ltd
CIK #0001491569, 0001055951
Sector Form 13F Holdings Value ($B)
Edgewise Therapeutics Inc 0.5
Imara Inc 0.3
Avita Medical Ltd 0.3
Mdxhealth Sa 0.3
Lilly Eli & Co 0.2
Boston Scientific Corp 0.1
Sionna Therapeutics Inc 0.1
Astrazeneca PLC 0.1
Myriad Genetics Inc 0.1
MBX Biosciences Inc 0.1
View All
Holdings by Sector ($B)
151296302011201620212027
EDGAR Form CIK 2011 - 2026
13F-HR [0001055951]
3 [0001055951]
4 [0001055951]
SC 13D [0001055951]
SC 13G [0001055951]
3 [0001491569]
4 [0001491569]
Form 13D/13G Filer Form 13D/13G Subject Filed
OrbiMed Advisors LLC Xilio Therapeutics Inc [2026-05-15]
OrbiMed Advisors LLC InspireMD Inc [2026-02-17]
OrbiMed Advisors LLC Cybin Inc [2026-02-17]
OrbiMed Advisors LLC Vistagen Therapeutics Inc [2025-11-14]
OrbiMed Advisors LLC CytomX Therapeutics Inc [2025-08-14]
OrbiMed Advisors LLC Whitehawk Therapeutics Inc [2025-05-15]
OrbiMed Advisors LLC ADC Therapeutics Sa [2025-02-14]
OrbiMed Advisors LLC RAPT Therapeutics Inc [2025-02-14]
OrbiMed Advisors LLC Forte Biosciences Inc [2025-02-14]
OrbiMed Advisors LLC Sionna Therapeutics Inc [2025-02-13]
View All
Form 3/4/5 Subject 2011 - 2026
Sionna Therapeutics Inc
OrbiMed Advisors LLC
OrbiMed Capital GP VIII LLC
OrbiMed Genesis GP LLC
OrbiMed Capital GP VII LLC
Enliven Therapeutics Inc
Shattuck Labs Inc
OrbiMed Capital GP IX LLC
Q32 Bio Inc
Traws Pharma Inc
Prelude Therapeutics Inc
OrbiMed Capital GP VI LLC
OrbiMed Capital LLC
ImageneBio Inc
OrbiMed Capital GP V LLC
OrbiMed Israel GP II LP
OrbiMed Israel BioFund GP Limited Partnership
Adicet Bio Inc
OrbiMed Advisors Israel II Ltd
OrbiMed Israel GP Ltd
Keros Therapeutics Inc
PMV Pharmaceuticals Inc
Turnstone Biologics Corp
Corvus Pharmaceuticals Inc
Passage Bio Inc
NeuroPace Inc
OrbiMed ROF II LLC
Xtant Medical Holdings Inc
Compass Therapeutics Inc
Edgewise Therapeutics Inc
Disc Medicine Inc
MBX Biosciences Inc
Lomond Therapeutics Holdings Inc
Upstream Bio Inc
ARS Pharmaceuticals Inc
scPharmaceuticals Inc
OrbiMed Advisors III Ltd
Terns Pharmaceuticals Inc
OrbiMed Asia GP III LP
TELA Bio Inc
OrbiMed Capital GP IV LLC
Alpine Immune Sciences Inc
Kinnate Biopharma Inc
OrbiMed Advisors IV Ltd
OrbiMed Asia GP IV LP
Theseus Pharmaceuticals Inc
ArriVent BioPharma Inc
Damora Therapeutics Inc
Chimovits Erez
Verona Pharma PLC
Tricida Inc
Third Harmonic Bio Inc
SpringWorks Therapeutics Inc
ProNAi Therapeutics Inc
Arcutis Biotherapeutics Inc
89bio Inc
Janux Therapeutics Inc
Repare Therapeutics Inc
Acutus Medical Inc
Synlogic Inc
Oric Pharmaceuticals Inc
Decibel Therapeutics Inc
Prevail Therapeutics Inc
CTI Biopharma Corp
Zeta Acquisition Corp II
LogicBio Therapeutics Inc
Graybug Vision Inc
Inspire Medical Systems Inc
Pandion Therapeutics Inc
Fusion Pharmaceuticals Inc
Alector LLC
OrbiMed Global Healthcare GP LLC
Principia Biopharma Inc
NextCure Inc
Turning Point Therapeutics Inc
Avedro Inc
Synthorx Inc
Si-Bone Inc
Guardant Health Inc
Arvinas Inc
SteadyMed Ltd
Mirax Corp
OrbiMed Capital GP III LLC
Constellation Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
ARMO BioSciences Inc
Adaptimmune Therapeutics PLC
Rhythm Pharmaceuticals Inc
Palvella Therapeutics Inc
Audentes Therapeutics Inc
GLAUKOS Corp
Kala Bio Inc
Isaly Samuel D
Loxo Oncology Inc
X4 Pharmaceuticals Inc
Sorrento Tech Inc
Spyre Therapeutics Inc
Nabriva Therapeutics AG
OrbiMed Asia GP LP
Response Biomedical Corp
OrbiMed Advisors Ltd
Relypsa Inc
Selecta Biosciences Inc
Intellia Therapeutics Inc
Otonomy Inc
Dimension Therapeutics Inc
Project Sage Oldco Inc
OrbiMed Private Investments V LP
Intercept Pharmaceuticals Inc
Mirati Therapeutics Inc
Acceleron Pharma Inc
OrbiMed Capital GP II LLC
Ambit Biosciences Corp
Supernus Pharmaceuticals Inc
Anthera Pharmaceuticals Inc
Amarin Corp PLC UK
Complete Genomics Inc
Pacira BioSciences Inc
ChemoCentryx Inc
OrbiMed Capital GP I LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Sionna Therapeutics Inc SION
Common Stock
2026-02-03 Sell 29,063 $44.58 1,295,629
Sionna Therapeutics Inc SION
Common Stock
2026-02-02 Sell 1,890 $44.57 84,237
Sionna Therapeutics Inc SION
Common Stock
2025-12-24 Sell 33,356 $44.55 1,486,010
Sionna Therapeutics Inc SION
Common Stock
2025-12-19 Sell 875 $44.49 38,929
Sionna Therapeutics Inc SION
Common Stock
2025-12-18 Sell 100 $44.49 4,449
Sionna Therapeutics Inc SION
Common Stock
2025-12-17 Sell 900 $44.50 40,050
Sionna Therapeutics Inc SION
Common Stock
2025-11-26 Sell 1,600 $44.49 71,184
Sionna Therapeutics Inc SION
Common Stock
2025-11-25 Sell 11,890 $44.60 530,294
Sionna Therapeutics Inc SION
Common Stock
2025-11-24 Sell 94,583 $44.54 4,212,727
Keros Therapeutics Inc KROS
Common Stock
2025-11-21 Disposed to issuer 74,465 $17.75 1,321,754
Keros Therapeutics Inc KROS
Common Stock
2025-11-21 Disposed to issuer 140,057 $17.75 2,486,012
PMV Pharmaceuticals Inc PMVP
Common Stock
2025-10-23 Sell 1,000,000 $1.52 1,520,000
Adicet Bio Inc ACET
Common Stock
2025-10-08 Buy 3,500,000 $1.00 3,500,000
Adicet Bio Inc ACET
Common Stock
2025-10-08 Buy 1,500,000 $1.00 1,500,000
Turnstone Biologics Corp TSBX
Common Stock
2025-08-08 Tender 3,099,265
ImageneBio Inc IKNA
Common Stock
2025-07-25 Grant 83,611 $2.49 208,191
Corvus Pharmaceuticals Inc CRVS
Common Warrants (right to buy) · derivative
2025-06-27 Option exercise 1,397,684 $0.00
Corvus Pharmaceuticals Inc CRVS
Common Stock
2025-06-27 Option exercise 1,397,684 $3.50 4,891,894
Corvus Pharmaceuticals Inc CRVS
Common Stock
2025-06-27 Sell 1,176,332 $4.16 4,893,541
Passage Bio Inc PASG
Common Stock
2025-06-26 Sell 213,257 $0.33 70,375
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com